Cognition Therapeutics, Inc. · NASDAQ:CGTX
Doyle John Brendan bought 10,000 Cognition Therapeutics, Inc. shares (Form 4)
Traded Apr 16, 2026 · Filed Apr 20, 2026
On Apr 16, 2026, Doyle John Brendan (Chief Financial Officer) bought 10,000 Cognition Therapeutics, Inc. shares at US$1.13 for US$11,300, leaving 627,509 shares. Filed Apr 20, 2026 (Form 4).
- Bought
- 10,000 shares
- Price
- US$1.13
- Value
- US$11,300
- Holding after
- 627,509 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 16, 2026 | Common Stock | Buy | 10,000 | US$1.13 | 627,509 | Direct |
Source
Related
- Cognition Therapeutics, Inc.
- Doyle John Brendan
- Cognition Therapeutics, Inc. shareholders
- Form 4 · Doyle John Brendan · May 4, 2026
- Form 4 · Khattar Jack A. · Jun 22, 2026
- Form 4 · Monia Brett P · Jun 22, 2026
- Form 4 · Wallace Peggy · Jun 22, 2026
- Form 4 · Richstone Ellen B · Jun 22, 2026
- Form 4 · BIOS Memory SPV I, LP · Jun 22, 2026